OncoMed Pharmaceuticals Inc (OMED.O) Company Profile
OncoMed Pharmaceuticals, Inc. (OncoMed) incorporated on July 19, 2004, is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential targets and pathways critical to....More>>>
News about OMED
Silver: Once and Future Money
The Roman Republic and the later Roman Empire had gold coins called the aureus and solidus, but they also minted a popular silver coin called the denarius. One denarius was the daily wage for unskilled labor and Roman soldiers.Of course, in the late ...Read More>>>
Australia Has Its Work Cut Out to Reprise Jobs Bonanza in 2018
If history is any guide, the Australian job market’s phenomenal pickup in 2017 won’t be repeated this year. Can it buck tradition?Westpac Banking Corp. estimates the current annual jobs growth of 3.2 percent is equivalent to U.S. payrol...Read More>>>
Ford Revives Ranger as Truck Sales Boom Beckons Return to U.S.
Big-truck king Ford Motor Co. has been missing out on soaring mid-size pickup sales. It’s now bringing its Ranger model back to make up for lost time.The American version of the Ranger debuting Sunday at the Detroit auto show and going on sale...Read More>>>
David Rolfe Comments on Apple Inc.
Apple (NASDAQ:AAPL)“You have to go back to Rockefeller and Standard Oil to find a company so dominant in a business so large,” says David Rolfe (Trades, Portfolio), chief investment officer at Wedgewood Partners, which manages $5 billion....Read More>>>
This Notoriously Cyclical Sector Is Starting to Boom
One "left for dead" asset class is quietly moving higher again... Since bottoming in late June, the Bloomberg Commodity Index – which tracks nearly two dozen commodities across energy, grains, precious metals, indus...Read More>>>